NCT01636687 - Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) | Biotech Hunter

Enrollment

182

Participants

Timeline

Start Date

October 17, 2012

Primary Completion Date

October 27, 2016

Study Completion Date

October 27, 2016

Conditions

Plaque-type Psoriasis

Interventions

DRUG

Placebo

2 injections of placebo to secukinumab 150mg per dose

DRUG

Secukinumab 150mg

Secukinumab 150mg: 1 injection of 150 mg secukinumab and 1 injection of placebo to secukinumab 150mg per dose. After Week 52 database lock, study is open label so only 1 injection of secukinumab 150mg per dose were administered

DRUG

Secukinumab 300mg

Secukinumab 300mg (2 injections of 150mg secukinumab per dose)

Trial Locations (39)

10134

Novartis Investigative Site, Tallinn

13619

Novartis Investigative Site, Tallinn

14623

Novartis Investigative Site, Rochester

16635

Novartis Investigative Site, Duncansville

22143

Novartis Investigative Site, Hamburg

22391

Novartis Investigative Site, Hamburg

23507

Novartis Investigative Site, Norfolk

31400

Novartis Investigative Site, Toulouse

33647

Novartis Investigative Site, Bielefeld

37203

Novartis Investigative Site, Nashville

40202

Novartis Investigative Site, Louisville

40291

Novartis Investigative Site, Louisville

48149

Novartis Investigative Site, Münster

49074

Novartis Investigative Site, Osnabrück

53105

Novartis Investigative Site, Bonn

56242

Novartis Investigative Site, Selters

60590

Novartis Investigative Site, Frankfurt

66215

Novartis Investigative Site, Overland Park

68144

Novartis Investigative Site, Omaha

69115

Novartis Investigative Site, Heidelberg

72076

Novartis Investigative Site, Tübingen

85032

Novartis Investigative Site, Phoenix

86021

Novartis Investigative Site, Poitiers

86163

Novartis Investigative Site, Augsburg

86179

Novartis Investigative Site, Augsburg

90045

Novartis Investigative Site, Los Angeles

91054

Novartis Investigative Site, Erlangen

92056

Novartis Investigative Site, Oceanside

93053

Novartis Investigative Site, Regensburg

02919

Novartis Investigative Site, Johnston

T3A 2N1

Novartis Investigative Site, Calgary

B3H 1Z2

Novartis Investigative Site, Halifax

L8N 1V6

Novartis Investigative Site, Hamilton

L5H 1G9

Novartis Investigative Site, Mississauga

H3H 1V4

Novartis Investigative Site, Montreal

G1V 4X7

Novartis Investigative Site, Sainte-Foy

06202

Novartis Investigative Site, Nice

01307

Novartis Investigative Site, Dresden

07548

Novartis Investigative Site, Gera